ATE353642T1 - Verwendung von hypoestoxiden als antiparasitäre mittel - Google Patents

Verwendung von hypoestoxiden als antiparasitäre mittel

Info

Publication number
ATE353642T1
ATE353642T1 AT00947101T AT00947101T ATE353642T1 AT E353642 T1 ATE353642 T1 AT E353642T1 AT 00947101 T AT00947101 T AT 00947101T AT 00947101 T AT00947101 T AT 00947101T AT E353642 T1 ATE353642 T1 AT E353642T1
Authority
AT
Austria
Prior art keywords
hypoestoxides
antiparasitive
agents
insultors
theeof
Prior art date
Application number
AT00947101T
Other languages
English (en)
Inventor
Emmanuel A Ojo-Amaize
Joseph I Okogun
Emeka J Nchekwube
Original Assignee
Paraquest Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paraquest Inc filed Critical Paraquest Inc
Application granted granted Critical
Publication of ATE353642T1 publication Critical patent/ATE353642T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT00947101T 1999-07-06 2000-07-06 Verwendung von hypoestoxiden als antiparasitäre mittel ATE353642T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/347,900 US6242484B1 (en) 1999-07-06 1999-07-06 Hypoestoxides, derivatives and agonists thereof for use of antiparasitic agents

Publications (1)

Publication Number Publication Date
ATE353642T1 true ATE353642T1 (de) 2007-03-15

Family

ID=23365772

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00947101T ATE353642T1 (de) 1999-07-06 2000-07-06 Verwendung von hypoestoxiden als antiparasitäre mittel

Country Status (6)

Country Link
US (1) US6242484B1 (de)
EP (1) EP1225892B1 (de)
AT (1) ATE353642T1 (de)
AU (1) AU6076500A (de)
DE (1) DE60033416T2 (de)
WO (1) WO2001001975A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1143646A1 (de) 2000-04-05 2001-10-10 Telefonaktiebolaget Lm Ericsson Optisches Kommunikationssystem mit zwei parallelen Übertragungswegen
WO2003022266A1 (en) * 2001-08-24 2003-03-20 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use as inhibitors of angiongenesis
CA2509834A1 (en) * 2002-10-28 2004-05-13 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia
WO2004062590A2 (en) * 2003-01-07 2004-07-29 Kemin Pharma Europe B.V.B.A. Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
US7229979B2 (en) * 2003-06-23 2007-06-12 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents
US20050112071A1 (en) * 2003-10-23 2005-05-26 Paraquest, Inc. Hypoestoxides, derivatives, agonists and crude extracts thereof for use in cosmetic compositions
US20060094695A1 (en) * 2004-11-02 2006-05-04 Paraquest, Inc. Hypoestoxides, derivatives and agonists thereof for use in the prophylaxis and treatment of obesity
US8124654B2 (en) * 2008-11-11 2012-02-28 Immune Modulation, Inc. Derivatives of hypoestoxide and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001871A (en) * 1998-01-15 1999-12-14 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as antiviral agents
US5801193A (en) * 1997-04-15 1998-09-01 Immune Modulation, Inc. Compositions and methods for immunosuppressing
US5994328A (en) * 1998-01-14 1999-11-30 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as anticancer agents

Also Published As

Publication number Publication date
DE60033416D1 (de) 2007-03-29
AU6076500A (en) 2001-01-22
EP1225892B1 (de) 2007-02-14
EP1225892A2 (de) 2002-07-31
WO2001001975A3 (en) 2002-05-23
US6242484B1 (en) 2001-06-05
WO2001001975A2 (en) 2001-01-11
DE60033416T2 (de) 2007-11-29

Similar Documents

Publication Publication Date Title
MXPA03007140A (es) Derivados de carbolina.
DE69928952D1 (de) Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe
DE69941429D1 (de) 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a
TR200101793T2 (tr) CCR5 modülatörleri olarak azabisikloalkanlar
ATE376996T1 (de) Antibakterielle mittel
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
DE60035032D1 (de) Verwendung von pioglitazone zur verbesserung der ketose und der azidose
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
DE50211045D1 (de) Medizinische aerosolformulierungen
NO992282L (no) Benzonaftyridiner som bronkialterapentika
AU2001266575A1 (en) Chemical compounds
AU2002317501A1 (en) Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
AU2003280918A1 (en) Rabbit skin comprising biological active substance and its use
NO2019032I1 (no) Treosulfan
RS51478B (sr) Upotreba bradikardijskih supstanci u lečenju miokardnih oboljenja povezanih sa hipertrofijom i nove kombinacije lekova
DK1330258T3 (da) Kahalalid F-formulering
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
DE60033918D1 (de) Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
ATE353642T1 (de) Verwendung von hypoestoxiden als antiparasitäre mittel
SE0102147D0 (sv) New methods
PT1147088E (pt) 6-arilfenantridinas com actividade inibitoria da pde-iv
DE60008400D1 (de) Triazolopyrimidinderivate
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
ATE416782T1 (de) Medizinische verwendung von il-174 agonisten und antagonisten
DK1331940T3 (da) Anvendelse af det lange pentraxin PTX3 til behandling af sygdomme forårsaget af ændret aktivering af vækstfaktoren FGF-2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties